A Yu Selected Research

A Yu Research Topics

Disease

8	Neoplasms (Cancer) 01/2013 - 05/2000
3	Infections 09/2011 - 05/2000
2	Hemorrhage 01/2019 - 01/2003
1	Nausea 10/2019
1	Birth Weight (Birth Weights) 01/2019
1	Lung Diseases (Lung Disease) 01/2019
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2019
1	Acute Intermittent Porphyria (Porphyria, Acute) 01/2018
1	Inguinal Hernia (Direct Inguinal Hernia) 01/2018
1	Hepatitis 01/2017
1	type 2 alpha 1 Collagenopathy 09/2015
1	Colorectal Neoplasms (Colorectal Cancer) 01/2015
1	Tobacco Use Disorder (Nicotine Dependence) 01/2015
1	Postoperative Pain 01/2015
1	Carcinogenesis 01/2015
1	Necrosis 01/2015
1	Obesity 10/2013
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 02/2013
1	Open-Angle Glaucoma (Glaucoma, Open Angle) 02/2013
1	Ocular Hypertension (Glaucoma, Suspect) 02/2013
1	Glaucoma 02/2013
1	Anaphylaxis (Anaphylactic Shock) 01/2013
1	Fibrosis (Cirrhosis) 08/2012
1	Breast Neoplasms (Breast Cancer) 12/2007
1	Macular Degeneration (Age-Related Maculopathy) 11/2007
1	Cytomegalovirus Infections (Inclusion Disease) 10/2007
1	Erectile Dysfunction 01/2007
1	Myalgia 09/2005
1	Myositis (Idiopathic Inflammatory Myopathies) 09/2005
1	Inflammation (Inflammations) 09/2005
1	Back Pain (Backache) 09/2005
1	Fistula 01/2003
1	Thromboembolism 01/2003
1	Disease Susceptibility (Diathesis) 01/2003
1	Pancreatic Neoplasms (Pancreatic Cancer) 06/2002
1	Prostatic Neoplasms (Prostate Cancer) 06/2002
1	Pancreatitis 11/2001
1	Sepsis (Septicemia) 10/2001
1	Paraproteinemias (Monoclonal Gammopathy) 10/2001
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 07/2000

Drug/Important Bio-Agent (IBA)

3	Biomarkers (Surrogate Marker)IBA 01/2018 - 09/2005
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2007 - 06/2002
2	Tadalafil (Cialis)FDA Link 01/2007 - 09/2005
2	Proteins (Proteins, Gene)FDA Link 07/2000 - 05/2000
1	PlacebosIBA 10/2019
1	Surface-Active Agents (Surfactants)IBA 01/2019
1	Oxygen (Dioxygen)IBA 01/2019
1	Procollagen Type IIBA 01/2018
1	procollagen Type III-N-terminal peptide (PIIP)IBA 01/2018
1	Aminolevulinic Acid (Levulan)FDA Link 01/2018
1	Collagen Type III (Type III Collagen)IBA 01/2018
1	Matrix Metalloproteinases (MMPs)IBA 01/2018
1	CollagenIBA 01/2018
1	CopperIBA 01/2018
1	ZincIBA 01/2018
1	Heme (Haem)IBA 01/2018
1	ProcollagenIBA 01/2018
1	Hydroxymethylbilane Synthase (Porphobilinogen Deaminase)IBA 01/2018
1	Prescription DrugsIBA 01/2017
1	Protein Kinases (Protein Kinase)IBA 01/2015
1	Indicators and Reagents (Reagents)IBA 01/2015
1	Opioid Analgesics (Opioids)IBA 01/2015
1	Propidium (Propidium Iodide)IBA 01/2015
1	Phosphotransferases (Kinase)IBA 01/2015
1	AnnexinsIBA 01/2015
1	Insulin (Novolin)FDA Link 10/2013
1	Papillomavirus Vaccines (HPV Vaccines)IBA 02/2013
1	ProstaglandinsIBA 02/2013
1	FlavonoidsIBA 01/2013
1	QuercetinIBA 01/2013
1	AntioxidantsIBA 01/2013
1	Hepatitis B e AntigensIBA 08/2012
1	Biocompatible Materials (Biomaterials)IBA 09/2011
1	Estrogen ReceptorsIBA 12/2007
1	Estrogen Receptor alphaIBA 12/2007
1	Bevacizumab (Avastin)FDA Link 11/2007
1	Antiviral Agents (Antivirals)IBA 10/2007
1	Type 5 Cyclic Nucleotide PhosphodiesterasesIBA 09/2005
1	Prothrombin (Factor II)IBA 01/2003
1	fibrin fragment D (D-dimer)IBA 01/2003
1	FibrinIBA 01/2003
1	Peptide YYIBA 06/2002
1	Hormones (Hormone)IBA 06/2002
1	Gastrointestinal Hormones (Hormones, Gastrointestinal)IBA 06/2002
1	neuropeptide Y4 receptorIBA 06/2002
1	Vitamin E FDA LinkGeneric 06/2002
1	Dihydrotachysterol (AT 10)IBA 06/2002
1	alpha-Tocopherol FDA Link 06/2002
1	Dipyridamole (Persantine)FDA LinkGeneric 11/2001
1	CeruletideIBA 11/2001
1	Vasodilator Agents (Vasodilators)IBA 11/2001
1	C-Reactive ProteinIBA 10/2001
1	Immunoglobulin M (IgM)IBA 10/2001
1	Interleukin-2 (IL2)IBA 09/2000
1	AntigensIBA 07/2000

Therapy/Procedure

4	Therapeutics 02/2013 - 05/2000
1	Kidney Transplantation 10/2007
1	Catheters 01/2003
1	Continuous Ambulatory Peritoneal Dialysis (CAPD) 05/2001
1	Drug Therapy (Chemotherapy) 07/2000